Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity
Naijin Xu(Zhejiang University), Peng Huang(Jiujiang University)
Cited by 17
Related Papers
Cancer stem cell-like characteristics of a CD133+ subpopulation in the J82 human bladder cancer cell line
|Molecular and Clinical Oncology|2012|40
Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer
|International Journal of Biological Sciences|2021|32
The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer
|International Journal of Biological Sciences|2019|31
Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1
|International Journal of Nanomedicine|2021|25